BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31877405)

  • 1. Emerging roles of F-box proteins in cancer drug resistance.
    Yan L; Lin M; Pan S; Assaraf YG; Wang ZW; Zhu X
    Drug Resist Updat; 2020 Mar; 49():100673. PubMed ID: 31877405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of F-box proteins by noncoding RNAs in human cancers.
    Lin M; Xu Y; Gao Y; Pan C; Zhu X; Wang ZW
    Cancer Lett; 2019 Dec; 466():61-70. PubMed ID: 31546023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of F-BOX proteins in progression and development of human malignancies.
    Uddin S; Bhat AA; Krishnankutty R; Mir F; Kulinski M; Mohammad RM
    Semin Cancer Biol; 2016 Feb; 36():18-32. PubMed ID: 26410033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-box proteins in cancer stemness: An emerging prognostic and therapeutic target.
    Khan AQ; Al-Tamimi M; Uddin S; Steinhoff M
    Drug Discov Today; 2021 Dec; 26(12):2905-2914. PubMed ID: 34265459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting SCF E3 Ligases for Cancer Therapies.
    Liu J; Peng Y; Zhang J; Long J; Liu J; Wei W
    Adv Exp Med Biol; 2020; 1217():123-146. PubMed ID: 31898226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in SCF ubiquitin ligase complex: Clinical implications.
    Zheng N; Zhou Q; Wang Z; Wei W
    Biochim Biophys Acta; 2016 Aug; 1866(1):12-22. PubMed ID: 27156687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of F-box proteins in cancer.
    Wang Z; Liu P; Inuzuka H; Wei W
    Nat Rev Cancer; 2014 Apr; 14(4):233-47. PubMed ID: 24658274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.
    Hussain M; Lu Y; Liu YQ; Su K; Zhang J; Liu J; Zhou GB
    Pharmacol Res; 2016 Sep; 111():34-42. PubMed ID: 27238229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
    Wang X; Zhang T; Zhang S; Shan J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
    [No Abstract]   [Full Text] [Related]  

  • 12. F-box protein interactions with the hallmark pathways in cancer.
    Randle SJ; Laman H
    Semin Cancer Biol; 2016 Feb; 36():3-17. PubMed ID: 26416465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy.
    Chen S; Lin J; Zhao J; Lin Q; Liu J; Wang Q; Mui R; Ma L
    Front Oncol; 2023; 13():1147239. PubMed ID: 36998461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.
    Heo J; Eki R; Abbas T
    Semin Cancer Biol; 2016 Feb; 36():33-51. PubMed ID: 26432751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule therapeutics targeting F-box proteins in cancer.
    Liu Y; Mallampalli RK
    Semin Cancer Biol; 2016 Feb; 36():105-19. PubMed ID: 26427329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers.
    Song Y; Lin M; Liu Y; Wang ZW; Zhu X
    Stem Cell Res Ther; 2019 Apr; 10(1):124. PubMed ID: 30999935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
    Qiao Y; Zhang Y; Wang J
    Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCF ubiquitin ligase-targeted therapies.
    Skaar JR; Pagan JK; Pagano M
    Nat Rev Drug Discov; 2014 Dec; 13(12):889-903. PubMed ID: 25394868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of F-box proteins in human digestive system tumors (Review).
    Gong J; Lv L; Huo J
    Int J Oncol; 2014 Dec; 45(6):2199-207. PubMed ID: 25270675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
    Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.